Meeting
2014 Gastrointestinal Cancers Symposium
A prospective observational study on chemotherapy-induced nausea and vomiting for esophageal cancer patients in Japan.
Authors
Sachiko Yamamoto
Department of Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
Sachiko Yamamoto , Ryu Ishihara , Naoya Yoshida , Hideaki Shimada , Tsuyoshi Noguchi , Tatsuya Miyazaki , Takaki Yoshikawa , Takushi Yasuda , Yasuaki Nakajima , Yuko Kitagawa , Hideo Baba , Keisuke Aiba
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
UMIN000005971
Citation
J Clin Oncol 32, 2014 (suppl 3; abstr 135)
DOI
10.1200/jco.2014.32.3_suppl.135
Abstract #
135
Poster Bd #
D41
Abstract Disclosures
Similar Posters
Poster
2014 Gastrointestinal Cancers Symposium
A prospective multicenter observational study for chemotherapy-induced nausea and vomiting in gastric cancer in Japan.
First Author: Shiro Iwagami
Poster
2020 ASCO Virtual Scientific Program
Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting (CINV): Results of the Nausea/Emesis Registry in Oncology (NERO).
First Author: Matti S. Aapro
Poster
2019 ASCO Annual Meeting
Physician concordance with update to ASCO guidelines for antiemetic use with carboplatin AUC ≥ 4.
First Author: Rudolph M. Navari
Poster
2015 ASCO Annual Meeting
Impact of rolapitant on quality of life (QoL) in patients (pts) receiving highly emetogenic chemotherapy (HEC) and moderately emetogenic chemotherapy (MEC).
First Author: Martin Chasen